Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

BACKGROUND: In the absence of randomized studies directly comparing chimeric antigen receptor T cell therapies, this study used matching-adjusted indirect comparisons (MAIC) to evaluate the comparative efficacy and safety of lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Maloney, David G., Kuruvilla, John, Liu, Fei Fei, Kostic, Ana, Kim, Yeonhee, Bonner, Ashley, Zhang, Yixie, Fox, Christopher P., Cartron, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425084/
https://www.ncbi.nlm.nih.gov/pubmed/34493319
http://dx.doi.org/10.1186/s13045-021-01144-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425084/
https://www.ncbi.nlm.nih.gov/pubmed/34493319
http://dx.doi.org/10.1186/s13045-021-01144-9

Ejemplares similares